The IBN SINA Pharmaceutical Industry PLC (DSE: IBNSINA)
Health Care · Pharmaceuticals · BD
Tk315.00
-1.01% today · +3.5% 1Y
The IBN SINA Pharmaceutical Industry PLC (DSE: IBNSINA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $79.97M.
Over the last twelve months the share price has gained 3.5%, trading between 273.80 and 371.00.
Tweenvest scores The IBN SINA Pharmaceutical Industry PLC across four factors: quality 76/100, value 58/100, growth 53/100, dividend 52/100. Its strongest factor is quality.
IBNSINA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $79.97M
- Revenue (TTM)
- $109.89M
- P/E
- 12.48
- EPS
- 25.23
- Dividend yield
- 2.03%
- Beta (5Y)
- 0.16
- 52-week high
- Tk371.00
- 52-week low
- Tk273.80
- Avg volume (3M)
- —
- Shares outstanding
- 31.24M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Euroapi S.A.ENXTPA: EAPI | $80.83M | €0.75 | -1.06% |
| Laboratorios Richmond S.A.C.I.F.BASE: RICH | $80.66M | AR$1,520.00 | +2.36% |
| High Tech Pharm Co., Ltd.KOSDAQ: A106190 | $80.22M | ₩10,160.00 | +2.83% |
| Rafael Holdings, Inc.NYSE: RFL | $80.08M | $1.48 | -3.90% |
| Euro-Med Laboratories Phil., Inc.PSE: EURO | $79.57M | ₱1.21 | +0.83% |
| Island Pharmaceuticals LimitedASX: ILA | $79.23M | AU$0.39 | -3.75% |
| Bayer S.A.BVL: BAYERI1 | $78.92M | S/.— | — |
| Kilitch Drugs (India) LimitedBSE: 524500 | $78.45M | Rs216.05 | -3.35% |
Figures last refreshed Oct 4, 2026.